CA2007200A1 - Derives de 2-aminopyrimidinone - Google Patents

Derives de 2-aminopyrimidinone

Info

Publication number
CA2007200A1
CA2007200A1 CA2007200A CA2007200A CA2007200A1 CA 2007200 A1 CA2007200 A1 CA 2007200A1 CA 2007200 A CA2007200 A CA 2007200A CA 2007200 A CA2007200 A CA 2007200A CA 2007200 A1 CA2007200 A1 CA 2007200A1
Authority
CA
Canada
Prior art keywords
piperidinyl
subjects suffering
treating subjects
aminopyrimidinone
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2007200A
Other languages
English (en)
Other versions
CA2007200C (fr
Inventor
Ludo E. J. Kennis
Jan Vandenberk
Jozef M. Boey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2007200A1 publication Critical patent/CA2007200A1/fr
Application granted granted Critical
Publication of CA2007200C publication Critical patent/CA2007200C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA002007200A 1989-01-09 1990-01-05 Derives de 2-aminopyrimidinone Expired - Fee Related CA2007200C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898900382A GB8900382D0 (en) 1989-01-09 1989-01-09 2-aminopyrimidinone derivatives
GB89.00.382.6 1989-01-09

Publications (2)

Publication Number Publication Date
CA2007200A1 true CA2007200A1 (fr) 1990-07-09
CA2007200C CA2007200C (fr) 1999-07-20

Family

ID=10649779

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002007200A Expired - Fee Related CA2007200C (fr) 1989-01-09 1990-01-05 Derives de 2-aminopyrimidinone

Country Status (25)

Country Link
EP (1) EP0378255B1 (fr)
JP (1) JP2938492B2 (fr)
KR (1) KR0159099B1 (fr)
CN (1) CN1034865C (fr)
AT (1) ATE104971T1 (fr)
AU (1) AU617918B2 (fr)
CA (1) CA2007200C (fr)
DE (1) DE69008366T2 (fr)
DK (1) DK0378255T3 (fr)
ES (1) ES2055860T3 (fr)
FI (1) FI94525C (fr)
GB (1) GB8900382D0 (fr)
HU (1) HU203747B (fr)
IE (1) IE62874B1 (fr)
IL (1) IL92730A (fr)
JO (1) JO1605B1 (fr)
MA (1) MA21722A1 (fr)
MY (1) MY106259A (fr)
NO (1) NO173139C (fr)
NZ (1) NZ231788A (fr)
PT (1) PT92806B (fr)
RU (1) RU2028297C1 (fr)
TN (1) TNSN90003A1 (fr)
ZA (1) ZA90123B (fr)
ZW (1) ZW290A1 (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0347146B1 (fr) * 1988-06-16 1993-09-01 Smith Kline & French Laboratories Limited Dérivés de pyrimidine condensés, procédé et intermédiaires pour leur préparation et compositions pharmaceutiques les contenant
GB9008850D0 (en) * 1990-04-19 1990-06-13 Janssen Pharmaceutica Nv Novel 2,9-disubstituted-4h-pyridol(1,2-a)pyrimidin-4-ones
US5075315A (en) * 1990-05-17 1991-12-24 Mcneilab, Inc. Antipsychotic hexahydro-2H-indeno[1,2-c]pyridine derivatives
US5143923B1 (en) * 1991-04-29 1993-11-02 Hoechst-Roussel Pharmaceuticals Incorporated Benzoisothiazole-and benzisoxazole-3-carboxamides
KR100251892B1 (ko) * 1992-07-13 2000-09-01 디르크 반테 신규한 4-(3-벤조푸라닐)피페리디닐 및 4-(3-벤조티에닐)피페리디닐 유도체 및 이들을 함유하는 약제학적 조성물
KR0179063B1 (ko) * 1993-02-04 1999-03-20 사사이 아키라 항정신병 작용을 갖는 화합물
GB9305623D0 (en) * 1993-03-18 1993-05-05 Merck Sharp & Dohme Therapeutic agents
US5521196A (en) * 1994-10-05 1996-05-28 Eli Lilly And Company 5-HT1F agonists for the treatment of migraine
US5521197A (en) * 1994-12-01 1996-05-28 Eli Lilly And Company 3-<1-alkylenearyl>-4-<1,2,3,6-tetrahydropyridinyl>-and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-HT1F agonists
TW421649B (en) * 1995-01-31 2001-02-11 Janssen Pharmaceutica Nv 4-(1H-indol-1yl)-1-piperidinyl derivatives
CN1184425A (zh) * 1995-03-20 1998-06-10 伊莱利利公司 5-取代-3-(1,2,3,6-四氢吡啶-4-基)-和3-(哌啶-4-基)-1h-吲哚:新型5-ht1f激动剂
ZA979781B (en) * 1996-11-14 1998-06-08 Akzo Nobel Nv Piperidine derivatives.
ES2165274B1 (es) * 1999-06-04 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
US6995144B2 (en) 2002-03-14 2006-02-07 Eisai Co., Ltd. Nitrogen containing heterocyclic compounds and medicines containing the same
ES2201907B1 (es) 2002-05-29 2005-06-01 Almirall Prodesfarma, S.A. Nuevos derivados de indolilpiperidina como potentes agentes antihistaminicos y antialergicos.
US20040242568A1 (en) 2003-03-25 2004-12-02 Syrrx, Inc. Dipeptidyl peptidase inhibitors
EP1911754B1 (fr) * 2003-08-13 2013-10-09 Takeda Pharmaceutical Company Limited Inhibiteurs de peptidase dipeptidyl
EP1506967B1 (fr) 2003-08-13 2007-11-21 Takeda Pharmaceutical Company Limited Inhibiteurs de dipeptidyl peptidase.
EP1699777B1 (fr) * 2003-09-08 2012-12-12 Takeda Pharmaceutical Company Limited Inhibiteurs de la dipeptidylpeptidase
MXPA06010571A (es) 2004-03-15 2007-02-16 Takeda Pharmaceutical Inhibidores de dipeptidil peptidasa.
US7371769B2 (en) 2004-12-07 2008-05-13 Solvay Pharmaceuticals B.V. Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites
RU2007125692A (ru) * 2004-12-07 2009-01-20 Солвей Фармасьютикалс Б.В. (Nl) Тетрагидропиридин-4-ил индолы с комбинацией свойств-сродства к допаминовым рецепторам d2 и центрами обратного захвата серотонина
US20070072870A2 (en) 2004-12-08 2007-03-29 Solvay Pharmeceuticals B.V. Phenylpiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition
EP1828192B1 (fr) 2004-12-21 2014-12-03 Takeda Pharmaceutical Company Limited Inhibiteurs de dipeptidyle peptidase
ME02005B (fr) 2005-09-14 2012-08-31 Takeda Pharmaceuticals Co Inhibiteurs de la dipeptidyl peptidase permettant de traiter le diabete
CN101360723A (zh) 2005-09-16 2009-02-04 武田药品工业株式会社 制备嘧啶二酮衍生物的方法
TW200813015A (en) 2006-03-15 2008-03-16 Mitsubishi Pharma Corp 2-(cyclic amino)-pyrimidone derivatives
US8324383B2 (en) 2006-09-13 2012-12-04 Takeda Pharmaceutical Company Limited Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
TW200838536A (en) 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
US8093236B2 (en) 2007-03-13 2012-01-10 Takeda Pharmaceuticals Company Limited Weekly administration of dipeptidyl peptidase inhibitors
PE20091236A1 (es) * 2007-11-22 2009-09-16 Astrazeneca Ab Derivados de pirimidina como immunomoduladores de tlr7
BR102012024778A2 (pt) * 2012-09-28 2014-08-19 Cristalia Prod Quimicos Farm Compostos heteroaromáticos; processo para preparar os compostos, composições farmacêuticas, usos e método de tratamento para as dores aguda e crônica
WO2015064714A1 (fr) * 2013-10-31 2015-05-07 国立大学法人東京大学 Dérivé substitué en position 1 d'imidazopyrimidinone ayant une activité inhibitrice sur l'autotaxine
PT3448859T (pt) 2017-03-20 2019-10-25 Forma Therapeutics Inc Composições de pirrolopirrole como ativadores de piruvato quinase (pkr).
ES2924359T3 (es) * 2017-04-11 2022-10-06 Sunshine Lake Pharma Co Ltd Compuestos de indazol sustituidos con flúor y usos de los mismos
US12053458B2 (en) 2018-09-19 2024-08-06 Novo Nordisk Health Care Ag Treating sickle cell disease with a pyruvate kinase R activating compound
ES2989438T3 (es) 2018-09-19 2024-11-26 Novo Nordisk Healthcare Ag Activación de la piruvato cinasa R
CN114615977B (zh) 2019-09-19 2025-01-14 诺沃挪第克健康护理股份公司 丙酮酸激酶r(pkr)活化组合物
US12128035B2 (en) 2021-03-19 2024-10-29 Novo Nordisk Health Care Ag Activating pyruvate kinase R

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443451A (en) * 1981-07-15 1984-04-17 Janssen Pharmaceutica N.V. Bicyclic pyrimidin-5-one derivatives
US4485107A (en) * 1982-11-01 1984-11-27 Janssen Pharmaceutica N.V. [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones
FR2537764A1 (fr) * 1982-12-08 1984-06-15 Framatome Sa Dispositif de commande de deux grappes de crayons de reglage deplacables verticalement dans un meme assemblage combustible du coeur d'un reacteur nucleaire
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
GB8900380D0 (en) * 1989-01-09 1989-03-08 Janssen Pharmaceutica Nv 2-aminopyrimidinone derivatives

Also Published As

Publication number Publication date
ZA90123B (en) 1991-09-25
HU900064D0 (en) 1990-03-28
CA2007200C (fr) 1999-07-20
KR900011755A (ko) 1990-08-02
NO173139B (no) 1993-07-26
EP0378255B1 (fr) 1994-04-27
IE62874B1 (en) 1995-03-08
ZW290A1 (en) 1991-09-11
DE69008366T2 (de) 1994-08-25
MY106259A (en) 1995-04-29
NZ231788A (en) 1990-12-21
AU617918B2 (en) 1991-12-05
MA21722A1 (fr) 1990-10-01
PT92806A (pt) 1990-07-31
EP0378255A2 (fr) 1990-07-18
RU2028297C1 (ru) 1995-02-09
IL92730A0 (en) 1990-09-17
IE900069L (en) 1990-07-09
KR0159099B1 (ko) 1998-12-01
DK0378255T3 (da) 1994-05-24
NO173139C (no) 1993-11-03
TNSN90003A1 (fr) 1991-03-05
CN1034865C (zh) 1997-05-14
DE69008366D1 (de) 1994-06-01
JPH02225482A (ja) 1990-09-07
PT92806B (pt) 1995-11-30
FI900085L (fi) 1990-07-10
ES2055860T3 (es) 1994-09-01
HU203747B (en) 1991-09-30
ATE104971T1 (de) 1994-05-15
EP0378255A3 (fr) 1991-01-09
NO900071L (no) 1990-07-10
FI94525C (fi) 1995-09-25
FI900085A0 (fi) 1990-01-08
CN1044094A (zh) 1990-07-25
IL92730A (en) 1993-06-10
GB8900382D0 (en) 1989-03-08
HUT52770A (en) 1990-08-28
FI94525B (fi) 1995-06-15
JP2938492B2 (ja) 1999-08-23
AU4777990A (en) 1990-07-12
JO1605B1 (en) 1990-07-01
NO900071D0 (no) 1990-01-08

Similar Documents

Publication Publication Date Title
CA2007200A1 (fr) Derives de 2-aminopyrimidinone
US5151423B1 (en) Heterocyclic n-oxide derivatives of substituted benzo(5,6)cycloheptapyridines, compositions and methods of use
IE851918L (en) An indole derivative.
AU6194694A (en) Nor-bile acid derivatives, processes for their preparation and the use of these compounds as medicaments
CA2216796A1 (fr) Derives de quinazoline
BG103268A (en) Propionic acid derivatives and their application
AU658619B2 (en) Benzopyranones, methods of manufacture and use thereof
HUT62290A (en) Process for producing imidazole derivatives substituted with aromatic group, as well as pharmaceutical compositions comprising same as active ingredient
UA48946C2 (uk) Арилалкілдіазинони, спосіб їх одержання (варіанти), фармацевтичний склад, спосіб його одержання та спосіб лікування
AU633754B2 (en) Composition for eye drops
CA2122911A1 (fr) Cycloalcenes et cycloalcanes substitues en 1,3, utilises comme agents du systeme nerveux central
CA2094702A1 (fr) Derives de substitution de tetrahydropyridines et d&#39;hydroxypiperidines, agents therapeutiques pour le systeme nerveux central
CA2138289A1 (fr) Derives azabicycloheptane substitues en n, leur preparation et leur utilisation
CA2041417A1 (fr) Traitement d&#39;une maladie du pancreas a l&#39;aide de composes de 15-ceto-prostaglandine
CA2046069A1 (fr) Traitement des maladies inflammatoires au moyen de composes de 15-cetoprostaglandine
AU5116590A (en) N-containing heterocyclic compounds, processes for the preparation thereof and composition comprising the same
HUT46508A (en) Insecticidal compositions comprising 6-member heterocyclic derivatives of n&#39;-substituted-n,n&#39;-diacylhydrazine and process for producing the active ingredients
HUT54358A (en) Process for producing substituted 1,3,5-triazinetrione derivatives and medical compositions comprising such compounds as active ingredient
CA2195747A1 (fr) Nouveaux derives substitues en position 3 de 3h-2,3-benzodiazepine, leur preparation et leur utilisation comme medicaments
EP1121932A4 (fr) Medicaments pour maladies oculaires
WO2001046178A3 (fr) Pyrroles substitues
AU5992990A (en) 14,17alpha-etheno- and -ethanoestratrienes, processes for the preparation of these compounds, as well as their use for the production of medicinal agents
CA2149007A1 (fr) Derives du cyclohexane, procede de preparation et utilisation de ces composes a des fins therapeutiques
WO2000002877A3 (fr) Nouveaux composes pharmaceutiques
AU1099688A (en) Substituted 3-phenyl-7h-thiazolo(2,2-b)(1,2,4)triazin-7-ones, a process for the preparation thereof, medicaments containing same and the use thereof, and also some intermediates formed in the preparation of the compounds mentioned

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed